Evolus Strategic Advantage and Growth
LOVVOLUS
A COMPELLING INVESTMENT OPPORTUNITY
UNDERPENETRATED AESTHETICS MARKET
estimated to nearly double by 2028*
VOLV
W
Total addressable market
EXPANDS BY 78%
with addition of HA filler portfolio*
evolu
Fully funded to
PROFITABILITY BY 2025**
Building a brand focused on the
YOUNGER DEMOGRAPHIC
GAINING MARKET SHARE IN
THE U.S.
while expanding internationally
UNIQUE CASH-PAY
BUSINESS MODEL
powered by strong digital capabilities
Source: Medical Insight, Inc. Cosmetic Neurotoxin Market Study, Jan. 2023, Medical Insights Dermal Filler Market Study, Mar. 2023 (www.miinews.com), BCG Aesthetic Research presented at IMCAS 2023 & company estimates.
** Within this presentation, "profitability" is defined as achieving positive non-GAAP operating income.
De
5View entire presentation